𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Co-amplification of 8p12 and 11q13 in breast cancers is not the result of a single genomic event

✍ Scribed by Anna L. Paterson; Jessica C. M. Pole; Katherine A. Blood; Maria J. Garcia; Susanna L. Cooke; Andrew E. Teschendorff; Yanzhong Wang; Suet-Feung Chin; Bauke Ylstra; Carlos Caldas; Paul A. W. Edwards


Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
885 KB
Volume
46
Category
Article
ISSN
1045-2257

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Epithelial cancers frequently have multiple amplifications, and particular amplicons tend to occur together. These co‐amplifications have been suggested to result from amplification of pre‐existing junctions between two chromosomes, that is, translocation junctions. We investigated this hypothesis for two amplifications frequent in breast cancer, at 8p12 and 11q13, which had been reported to be associated in Southern blot studies. We confirmed that both genomic amplification and expression of genes was correlated between the frequently‐amplified regions of 8p and 11q, in array CGH and microarray expression data, supporting the importance of co‐amplification. We examined by FISH the physical structure of co‐amplifications that we had identified by array CGH, in five breast cancer cell lines (HCC1500, MDA‐MB‐134, MDA‐MB‐175, SUM44, and ZR‐75‐1), four breast tumors, and a pancreatic cancer cell line (SUIT2). We found a variety of arrangements: amplification of translocation junctions; entirely independent amplification of the two regions on separate chromosomes; and separate amplification of 8p and 11q sequences in distinct sites on the same rearranged chromosome. In this last arrangement, interphase nuclei often showed intermingling of FISH signals from 8p12 and 11q13, giving a false impression that the sequences were interdigitated. We conclude that co‐amplification of the main 8p and 11q amplicons in breast tumors is not usually the result of a preceding translocation event but most likely reflects selection of clones that have amplified both loci. This article contains supplementary material available at http://www.interscience.wiley.com/jpages/1045‐2257/suppmat. © 2007 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


High-resolution genomic analysis of the
✍ Elin Karlsson; Marie Ahnström Waltersson; Josefine Bostner; Gizeh Pérez-Tenorio; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 604 KB

## Abstract The chromosomal region 11q13 is amplified in 15–20% of breast cancers; an event not only associated with estrogen receptor (ER) expression but also implicated in resistance to endocrine therapy. Coamplifications of the 11q13 and 8p12 regions are common, suggesting synergy between the am

CCND1 and FGFR1 coamplification results
✍ Silvia Bautista; Charles Theillet 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 797 KB

The CCND1 gene, localized to chromosome band 11q13, is amplified in approximately 15% of human primary breast tumors. From 30 to 40% of the tumors presenting this amplification show concomitant amplification at the FGFR1 locus in 8p12. Similarly, MDA-MB-134 breast cancer cells bear CCND1 and FGFR1 c

Loss of heterozygosity from the short ar
✍ M. Lisa Yarernko; Wendy M. Recant; Carol A. Westbrook 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 484 KB

Loss of heterozygosity (LOH) from the short arm of chromosome 8 (8p) is common t o many human carcinomas, including those of the colon and prostate. It localizes to two discrete regions, 8p21 and 8p22. This suggests the presence of at least two tumor suppressor genes (TSGs) on this chromosome arm. H